Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05697406
PHASE1/PHASE2

HP Pyruvate MRI in Cancers

Sponsor: University of Maryland, Baltimore

View on ClinicalTrials.gov

Summary

Many human diseases are characterized by their ability to alter existing metabolic pathways and interrupt cellular processes. Cancer exploits the Warburg effect and utilizes greater glucose than normal cells and within this process uses anaerobic respiration, leading to increased conversion of pyruvate to lactate. This can be exploited by hyperpolarized imaging. Hyperpolarized 13C MRI imaging is an approach that utilizes a stable isotope of Carbon (13C) linked to pyruvate. MRI spectroscopy is used in conjunction with hyperpolarized 13C pyruvate in order to temporally detect pyruvate and its conversion to lactate in-vivo, in order to visualize downstream metabolic (glycolytic) activity secondary to the Warburg effect, which should be useful in detecting and characterizing tumors of various types. Hyperpolarized 13C pyruvate MR imaging has not been tested in most cancers. In this preliminary survey, we will test the hypothesis that hyperpolarized 13C pyruvate MR imaging can be used to image various cancers.

Official title: Hyperpolarized 13-C Pyruvate MRI Surveillance of Multiple Cancers

Key Details

Gender

All

Age Range

18 Years - 88 Years

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2024-06-24

Completion Date

2028-12-01

Last Updated

2025-09-22

Healthy Volunteers

No

Interventions

DRUG

Hyperpolarized 13C-Pyruvate

Imaging tumors pre and post administration of hyperpolarized 13-C pyruvate injection.

Locations (1)

University of Maryland Medical Center

Baltimore, Maryland, United States